Table 3. Univariate and multivariable linear regression model predicting change in eGFR over one year follow-up.
Univariate Model | Multivariable Model | |||
---|---|---|---|---|
Predictors of change in eGFR at one year (ml/min/1.73m2 difference from baseline) | β Coefficient (95% CI) | P value | β Coefficient (95% CI) | P value |
Age, per 10 years | 0.40 (-3.33, 4.20) | 0.82 | -0.64 (-5.12, 3.84) | 0.77 |
Sex (male versus female) | -0.86 (-6.97,5.20) | 0.78 | 2.5 (-3.48, 8.53) | 0.4 |
Diabetes (versus non-diabetic) | -10.13 (-17.47, -2.79) | 0.008 | -6.09 (-13.45, 1.27) | 0.1 |
Cirrhosis (versus non-cirrhotic) | -5.67 (-11.43, -0.99) | 0.05 | -4.21 (-10.58, 2.15) | 0.19 |
HIV coinfection | 4.46 (-3.90, 12.83) | 0.29 | 5.19 (-3.42, 13.82) | 0.23 |
Baseline eGFR, per 10ml/min increase | -2.19 (-3.72, -0.66) | 0.006 | -1.18 (-3.70, 0.15) | 0.071 |
Significant creatinine rise during telaprevir | -6.65 (-29.74, -3.25) | 0.02 | -6.31 (-12.08, -0.53) | 0.03 |
Abbreviations: HIV = human immunodeficiency virus, eGFR = estimated glomerular filtration rate